(Updated - June 4, 2021 5:15 AM EDT)

Baird analyst Joel Beatty assumes coverage on Nurix (NASDAQ: NRIX) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE